GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » ALR Technologies SG Ltd (OTCPK:ALRTF) » Definitions » Net Current Asset Value

ALR Technologies SG (ALR Technologies SG) Net Current Asset Value : $-0.05 (As of Jun. 2023)


View and export this data going back to 1998. Start your Free Trial

What is ALR Technologies SG Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

ALR Technologies SG's net current asset value per share for the quarter that ended in Jun. 2023 was $-0.05.

The historical rank and industry rank for ALR Technologies SG's Net Current Asset Value or its related term are showing as below:

ALRTF's Price-to-Net-Current-Asset-Value is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 4.87
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

ALR Technologies SG Net Current Asset Value Historical Data

The historical data trend for ALR Technologies SG's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ALR Technologies SG Net Current Asset Value Chart

ALR Technologies SG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.12 -0.04 -0.04 -0.05 -0.05

ALR Technologies SG Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Dec22 Jun23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 -0.05 -0.05 -0.05 -0.05

Competitive Comparison of ALR Technologies SG's Net Current Asset Value

For the Medical Devices subindustry, ALR Technologies SG's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ALR Technologies SG's Price-to-Net-Current-Asset-Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, ALR Technologies SG's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where ALR Technologies SG's Price-to-Net-Current-Asset-Value falls into.



ALR Technologies SG Net Current Asset Value Calculation

ALR Technologies SG's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.155-32.071-0-0)/632.467
=-0.05

ALR Technologies SG's Net Current Asset Value (NCAV) per share for the quarter that ended in Jun. 2023 is calculated as

Net Current Asset Value Per Share(Q: Jun. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(0.681-30.398-0-0)/596.467
=-0.05

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


ALR Technologies SG  (OTCPK:ALRTF) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


ALR Technologies SG Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of ALR Technologies SG's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


ALR Technologies SG (ALR Technologies SG) Business Description

Traded in Other Exchanges
N/A
Address
7400 Beaufont Springs Drive, Suite 300, Richmond, VA, USA, 23225
ALR Technologies SG Ltd formerly ALR Technologies Inc is a medical device company, which focuses on commercializing its Health-e-Connect System. It has developed a compliance monitoring system that will allow healthcare professionals to remotely monitor patient health conditions and provide patient health management. The company's Health-e-Connect Remote Diabetes Management Program is remote monitoring and care facilitation program that allows patients to upload their blood glucose data from their glucometers. Its geographical segments are the United States, Singapore, and Others.
Executives
Sidney Chan director, officer: CEO 7400 BEAUFONT SPRINGS DRIVE, SUITE 300, SUITE 300, RICHMOND VA 23225
Ronald Cheng director 255 SPRINGFIELD ROAD, OTTAWA A6 K1M 0K8
Peter H Stafford director 1-405 81ST STREET, OSOYOOS A1 V0H 1V2
William S Smith director, officer: Chief Commercial Officer 46 CHESTNUT HILL ROAD, WILTON CT 06897
Kenneth Robulak director 521 MANDALAY AVENUE, APT. 302, CLEARWATER FL 33767
Alfonso Salas director 2106 WEST 33RD AVENUE, VANCOUVER A1 V6M 1B9
Lawrence A Weinstein director, officer: President 13436 BLUE HEON LOOP, CHESTERFIELD VA 23838
Jaroslav V Tichy officer: Vice-President - Technologies 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106
Stanley Cruitt director, 10 percent owner, officer: President 114M REYNOLDA VILLAGE, WINSTON-SALEM NC 27106